Home
NewsNewsArbor Fertility™ with 8 locations in Missouri & Illinois has designed a streamlined patient-centred approach leading to Affordable, Accessible Fertility Care, making high-quality treatment available without financial burden.
In 2024, the fertility rate in the United States hit an all-time low of only 1.6 births per woman. The fertility rate has been going down steadily since 2007, and it is now well below the 2.1 births per woman needed to keep the population stable. Career development, education, and financial planning are important, but they don't fully explain the decline. At the same time, infertility is on the rise at an alarming rate, with an estimated 1 in 6 people around the world affected. This makes it much more common than most people think.
Arbor Fertility has eight locations in Missouri and Illinois, and they see how hard it is for people in those states to pay for expensive fertility treatments. The cost of one IVF cycle can be anywhere from $23,000 to $40,000. When Arbor Fertility™ was set up, the organisation's leaders knew that fertility care needed a new model that combined advanced reproductive medicine with a greater emphasis on cost and access. The clinic got ahead of the curve by designing a streamlined, patient-centred approach that made it easier and cheaper to get high-quality fertility care.
Apparently, the cost of an Arbor Fertility™ IVF cycle is less than $15,000. That plan has helped Arbor Fertility™ quickly become a leader in fertility care in the region. It shows that new treatments can work and be affordable at the same time. Dr. Shvetha Zarek, founder and medical director of Arbor Fertility™, says, “Our goal from the beginning was to build a practice that removes barriers, and the recent efforts to decrease the cost of fertility medications also support patients immensely.”
At Arbor Fertility™, one of the most important things they do towards taking a step toward Affordable, Accessible Fertility Care is use new technologies like ProteX™ semen collection systems for treatment and home collection semen analysis kits, as well as low-needle IVF medication protocols. According to Dr. Zarek, “These innovations allow us to improve both the clinical and patient experience with success at national standards. For far too long, the fertility experience for the male partner has been largely ignored. We are working to reverse this trend, with focused fertility treatments to improve testosterone levels and sperm parameters.”
Arbor Fertility™ is becoming a regional leader by offering lower prices and a hub-and-spoke model for its offices. This makes it easier for more couples to reach their goal of starting a family. Dr. Zarek says, "Our motto is Grow Your Family Tree™. “Children, parents, and grandparents are all welcome in our clinic, as supporting generational family growth is our calling.”
3billion has gone on to launch the Family Insight Test using WES and WGS analysis aimed at targeting couples who cannot get pregnant for no apparent reason, helping them discover hidden genetic factors affecting fertility.
BGI Genomics, a Chinese biotechnology company is working on AI-Powered Chromosome Screening Tools so as to accelerate and enhance IVF treatments in China, aiming to reduce genetic abnormalities and increase live birth outcomes.
Before taking a call on IVF, survey conducted in the U.S., UK, Ireland, and Canada suggests that people are looking for complete & less expensive options to treat root causes of infertility.
The Tennessee State Law could change how the embryos are handled at the time of treatment, thereby making the IVF clinic services in the state more expensive for patients seeking fertility care.
CDSCO Orders on IVF Medical Devices reinforce strict regulatory oversight across India’s fertility sector. The directive mandates licensing compliance under existing laws, ensuring IVF and ART devices meet safety and quality standards. This move aims to curb unauthorized sales, strengthen enforcement, and bring greater accountability to medical device usage in reproductive healthcare.
Smart IUD to track uterus in real-time is being worked upon by Verso Biosense, which will help with data that has in the past been pretty hard to get, offering continuous intrauterine insights for better reproductive care.
